Trial intelligence / Profile preview

Atracurium for facilitating pediatric inguinal hernia surgery

IRCT20170829035978N1Phase 3Completed

Sponsor
Mashhad University of Medical Sciences
Start
Dec 2017
Modality
Small Molecules, Peptides
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of atracurium in inguinal hernia (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Surgeon's ease of seeing the hernial sac. Started Dec 2017; status: completed.

02

Drugs

atracurium
03

Conditions

inguinal hernia

Beyond the preview

Go deeper on IRCT20170829035978N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20170829035978N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call